NRIX
Nurix Therapeutics Inc

623
Mkt Cap
$1.99B
Volume
320.00
52W High
$22.50
52W Low
$8.18
PE Ratio
-6.43
NRIX Fundamentals
Price
$19.07
Prev Close
$19.61
Open
$19.63
50D MA
$13.27
Beta
1.61
Avg. Volume
1.54M
EPS (Annual)
-$2.88
P/B
3.94
Rev/Employee
$190,730.77
Loading...
Loading...
News
all
press releases
Nurix Therapeutics (NASDAQ:NRIX) Price Target Raised to $30.00 at Mizuho
Mizuho boosted their price target on Nurix Therapeutics from $24.00 to $30.00 and gave the company an "outperform" rating in a report on Wednesday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 5.4% - Here's Why
Nurix Therapeutics (NASDAQ:NRIX) Trading Down 5.4% - Here's What Happened...
MarketBeat·3d ago
News Placeholder
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Up - Time to Buy?
Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Up - Time to Buy...
MarketBeat·4d ago
News Placeholder
Nurix Therapeutics (NASDAQ:NRIX) Earns Buy Rating from Needham & Company LLC
Needham & Company LLC reiterated a "buy" rating and set a $26.00 price target on shares of Nurix Therapeutics in a research note on Monday...
MarketBeat·4d ago
News Placeholder
Bollard Group LLC Makes New $1.40 Million Investment in Nurix Therapeutics, Inc. $NRIX
Bollard Group LLC bought a new stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The...
MarketBeat·5d ago
News Placeholder
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) have received an average recommendation of "Moderate Buy" from the nineteen research firms that are presently covering the firm...
MarketBeat·10d ago
News Placeholder
Nurix Therapeutics, Inc. $NRIX Shares Sold by Intech Investment Management LLC
Intech Investment Management LLC trimmed its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 25.4% during the second quarter, according to its most recent Form 13F...
MarketBeat·12d ago
News Placeholder
Nurix Therapeutics (NASDAQ:NRIX) Coverage Initiated at Truist Financial
Truist Financial assumed coverage on shares of Nurix Therapeutics in a report on Monday. They set a "buy" rating and a $30.00 price objective on the stock...
MarketBeat·17d ago
News Placeholder
Nurix Therapeutics (NASDAQ:NRIX) Shares Up 10.4% - Should You Buy?
Nurix Therapeutics (NASDAQ:NRIX) Trading Up 10.4% - Here's Why...
MarketBeat·22d ago
News Placeholder
Candriam S.C.A. Sells 326,547 Shares of Nurix Therapeutics, Inc. $NRIX
Candriam S.C.A. lowered its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 55.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·25d ago

Latest NRIX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.